LYTE Clinics Subscribes to Strainprint Technologies to Boost Patient Engagement and Clinic Efficiency

Published: February 22, 2019

LYTE Clinics Subscribes to Strainprint Technologies to Boost Patient Engagement and Clinic Efficiency

Strainprint Technologies Ltd. announced that leading medical cannabis telehealth clinic, LYTE Clinics, has joined its growing list of subscribers. LYTE educates patients about medical cannabis and how to access it safely in Canada, helping patients acquire their medical cannabis authorization and gain access to licensed producers as a same day service.

“Aligning with Strainprint will open new doors not only for our patients, but to our educators and physicians as well,” says Ali Mohamad, President & CEO of Lyte Clinics. “Leveraging Strainprint’s highly intuitive, real-time data and analytics aligns with our commitment to using top-notch technology to provide our patients with optimal treatment guidance and a highly efficient and convenient user experience.”

LYTE will leverage Strainprint’s full scope of data and analytic technologies, starting with a LYTE-branded version of Strainprint’s mobile app. Their members will have access to the free app through a unique activation code, enabling them to track their treatment sessions in real-time to help achieve the best results for their symptoms. The app also includes loyalty tools that will help drive engagement through redeemable discounts on merchandise. Additionally, LYTE will access the Strainprint Analytics web platform, the most sophisticated cannabis analytics platform available, to monitor patient performance and provide better treatment experience. Strainprint Analytics is built on top of the largest and most granular scientific data set of its kind in the world, with more than 1.1 million anonymized, patient reported medical cannabis outcomes and over 50 million data points on strain efficacy.

LYTE is unique amongst cannabis clinics as the process of scheduling an appointment with a doctor, registering with a medical provider, and placing an order is all done online in a matter of minutes using state-of-art telehealth software. Educators and physicians are available for members to discuss different forms of consumption, strains and dosages. Integrating Strainprint’s recommendation platform will add another layer of technology to differentiate LYTE’s services.

“We’re looking forward to working with LYTE to serve their physicians and thousands of patients. We share the same philosophy and passion for improving lives through the education and fact-based treatment,” said Strainprint CEO, Andrew Muroff. “That common goal is made possible by using advanced technology and data.”